Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00776919 · ClinicalTrials.gov registry record · Phase 3
Trial of Clindamycin / Benzoyl Peroxide Gel in Subjects With Acne
A Phase 3 study, sponsored by Stiefel, a GSK Company.
- Completed
- Registry status
- Phase 3
- Development phase
- 1,315
- Enrollment target
NCT00776919: Completed Phase 3 study, sponsored by Stiefel, a GSK Company.
NCT00776919 is a Phase 3 study that has completed, run by Stiefel, a GSK Company. The registered enrollment target is 1,315 participants, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (70% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00776919, a Phase 3 study, has completed, sponsored by Stiefel, a GSK Company.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 1,315 participants
- Enrollment target
Study Summary
This is a Randomized, Double-Blind, Controlled Study to evaluate the Safety and Efficacy of a clindamycin / benzoyl peroxide gel in Subjects with Acne Vulgaris
Primary Outcome
During each study visit, investigators/assessors evaluated acne severity of the participants' faces using the ISGA scale: 0=clear skin with no lesions (L); 1=almost clear, rare non-inflammatory L; 2=mild, some non-inflammatory L with no more than a few inflammatory L, no nodular L; 3=moderate, many non-inflammatory L, may have some inflammatory L, but no more than 1 small nodular L; 4=severe, many non-inflammatory and inflammatory L, but no more than a few nodular L; 5=very severe, many non-infl
Interventions
- DRUG clindamycin / benzoyl peroxide gel
- DRUG clindamycin gel
- DRUG BPO gel
- DRUG vehicle gel
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,315 participants |
| Start Date | 2008-10 |
| Est. Completion | 2009-09 |
| Phase | Phase 3 |
What the finished NCT00776919 record still lists
NCT00776919 is an interventional study that assigns participants to a tested intervention. Its 1,315 participants enrollment target places it among the larger protocols in the corpus, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (70% higher).
The record links to 0 conditions, and to 4 interventions - of which clindamycin / benzoyl peroxide gel is the first listed.
NCT00776919 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00776919 about?
NCT00776919 is a clinical study titled "Trial of Clindamycin / Benzoyl Peroxide Gel in Subjects With Acne". This is a Randomized, Double-Blind, Controlled Study to evaluate the Safety and Efficacy of a clindamycin / benzoyl peroxide gel in Subjects with Acne Vulgaris
What is the current status of trial NCT00776919?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 1,315 participants. The study started on 2008-10. Estimated completion is 2009-09.
What interventions are being tested in trial NCT00776919?
The interventions under investigation include: clindamycin / benzoyl peroxide gel (DRUG), clindamycin gel (DRUG), BPO gel (DRUG), vehicle gel (DRUG).
Who is sponsoring clinical trial NCT00776919?
This trial is sponsored by Stiefel, a GSK Company, which has 37 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00776919's enrollment target sits among peer trials
1,315 185th of 2000 higher than 1,816 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05762302 · 1,316 participants · NA
The Impact of MeMed BV® on Management of Patients With Suspected Lower Respiratory Tract Infections (LRTI) in the Emergency Department (ED) and Urgent Care Center (UCC) ("JUPITER" TRIAL)
- NCT05176483 · 1,314 participants · Phase 1
Study of Zanzalintinib in Combination With Immuno-Oncology Agents in Participants With Solid Tumors
- NCT06136650 · 1,314 participants · Phase 3
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
- NCT06556433 · 1,312 participants · NA
Family-Based Financial Incentives Intervention for Smoking Cessation
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia